Project Oncology® CME presents a wide array of oncology CME topics designed to educate and enlighten practitioners on late-breaking discoveries, novel treatment options, evolving methods of patient management, and more. The series provides cutting-edge updates on cancer biology, diagnosis, and multidisciplinary management, as well as evidence-based recommendations to achieve optimal patient outcomes. Each program is designed to be a short, easy-to-digest format of 15 to 30 minutes.
Goals of Therapy for WHIM Syndrome (a Chronic Neutropenic Disorder)
Goals of Therapy for WHIM Syndrome (a Chronic Neutropenic Disorder)
WHIM Syndrome Management: The First FDA Approval for Patients
WHIM Syndrome Management: The First FDA Approval for Patients
You Don’t Know WHIM Syndrome (A Chronic Neutropenic Disorder)
You Don’t Know WHIM Syndrome (A Chronic Neutropenic Disorder)
WHIM Syndrome and CXCR4 Variants: New Insights into Cellular Changes That Can Impact Patient Treatment Plans
WHIM Syndrome and CXCR4 Variants: New Insights into Cellular Changes That Can Impact Patient Treatment Plans
Optimizing First-Line Immunotherapy for Recurrent or Metastatic HNSCC
Optimizing First-Line Immunotherapy for Recurrent or Metastatic HNSCC
Overcoming Barriers to Equitable Care in HNSCC
Overcoming Barriers to Equitable Care in HNSCC
Managing Immune-Related Adverse Events With Immunotherapies
Managing Immune-Related Adverse Events With Immunotherapies
The Role of Immunotherapy in the Treatment of Recurrent or Metastatic HNSCC: The Evidence
The Role of Immunotherapy in the Treatment of Recurrent or Metastatic HNSCC: The Evidence
Current and Emerging Biomarkers of Response to Immunotherapeutic Regimens
Current and Emerging Biomarkers of Response to Immunotherapeutic Regimens